MEETINGS - BioPartnering Europe conference (UK) October 2001:
This article was originally published in Clinica
Executive Summary
Investing in the convergence of biotech and information technology is the theme of the 9th BioPartnering Europe conference being held at the Queen Elizabeth II Conference Centre, London, UK, on October 14-16. For more information contact Technology Vision Group in the US. Tel: +1 831 464 7105. Fax: +1 831 464 4240. Email: [email protected] www.techvision.com
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.